2-((5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)thio)acetamide | 338424-96-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并嘧啶酮衍生物
• 英文名称: 2-((5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)thio)acetamide
• 英文别名: Cambridge id 6974608；2-(5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)sulfanylacetamide
• CAS: 338424-96-7
• 化学式: C₁₀H₁₁N₃OS₂
• mdl: MFCD02732543
• 分子量: 253.349
• InChiKey: JTVCTWHVKVPHOZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  122
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  (5,6-二甲基噻吩并[2,3-d]嘧啶-4-磺酰基)-乙酸 在 氨 、 Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 作用下， 生成 2-((5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)thio)acetamide
  参考文献：
  名称：

  Stimulation of cortical bone formation with thienopyrimidine based inhibitors of Notum Pectinacetylesterase

  摘要：

  A group of small molecule thienopyrimidine inhibitors of Notum Pectinacetylesterase are described. We explored both 2-((5,6-thieno[2,3-d]pyrimidin-4-yl)thio)acetic acids and 2-((6,7-thieno[3,2-d]pyrimidin-4-yl)thio)acetic acids. In both series, highly potent, orally active Notum Pectinacetylesterase inhibitors were identified. (C) 2016 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2016.02.021

文献信息

• INHIBITORS OF NOTUM PECTINACETYLESTERASE AND METHODS OF THEIR USE
  申请人：Lexicon Pharmaceuticals, Inc.

  公开号：EP2616471B1

  公开（公告）日：2014-12-31
• Stimulation of cortical bone formation with thienopyrimidine based inhibitors of Notum Pectinacetylesterase
  作者：James E. Tarver、Praveen K. Pabba、Joseph Barbosa、Qiang Han、Michael W. Gardyan、Robert Brommage、Andrea Y. Thompson、James M. Schmidt、Alan G.E. Wilson、Wei He、Victoria K. Lombardo、Kenneth G. Carson

  DOI：10.1016/j.bmcl.2016.02.021

  日期：2016.3

  A group of small molecule thienopyrimidine inhibitors of Notum Pectinacetylesterase are described. We explored both 2-((5,6-thieno[2,3-d]pyrimidin-4-yl)thio)acetic acids and 2-((6,7-thieno[3,2-d]pyrimidin-4-yl)thio)acetic acids. In both series, highly potent, orally active Notum Pectinacetylesterase inhibitors were identified. (C) 2016 Elsevier Ltd. All rights reserved.